tirzepatide while breastfeeding 📣 New Article Alert! Curious about and breastfeeding? 🤱 Our latest article breaks down what the current evidence says about tirzepatide transfer into breast milk. 👉 Read more here: https://infantrisk.com/content/what-breastfeeding-moms Tirzepatide and Breastfeeding: What Moms

Start at 0.6 mg SQ per day and increase by 0.6 mg per week as tolerated

They believed it differed from pancreozymin, another small intestine hormone identified by Ivy in 1928 that was subsequently renamed cholecystokinin (CCK) (Kosaka, Lim)

We offer education about limiting alcohol consumption, as this can impact both blood sugar management and weight loss efforts

Adopting optimal injection techniques and preparation strategies can significantly reduce the risk of injection site itching and other local reactions

Targeting both is less like doubling a dose and more like sending the same instruction down two independent phone lines

information on ongoing trials is available via the NIHR Be Part of Research service or ClinicalTrials.gov